These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35108369)

  • 1. Carbamylation of β2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of 'seronegative' patients.
    Capozzi A; Truglia S; Buttari B; Recalchi S; Riitano G; Manganelli V; Mancuso S; Alessandri C; Longo A; Mattei V; Profumo E; Garofalo T; Misasi R; Conti F; Sorice M
    Rheumatology (Oxford); 2022 Oct; 61(10):4187-4197. PubMed ID: 35108369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis.
    Capozzi A; Riitano G; Mancuso S; Recalchi S; Manganelli V; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Truglia S; Sorice M
    Clin Exp Immunol; 2021 Sep; 205(3):326-332. PubMed ID: 34107056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody profiles in the mosaic of 'seronegative' APS syndrome.
    Truglia S; Riitano G; Mancuso S; Recalchi S; Rapino L; Garufi C; Manganelli V; Garofalo T; Misasi R; Alessandri C; Sorice M; Longo A; Conti F; Capozzi A
    Clin Exp Immunol; 2024 Nov; 218(3):275-282. PubMed ID: 39192704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
    Ioannou Y; Zhang JY; Qi M; Gao L; Qi JC; Yu DM; Lau H; Sturgess AD; Vlachoyiannopoulos PG; Moutsopoulos HM; Rahman A; Pericleous C; Atsumi T; Koike T; Heritier S; Giannakopoulos B; Krilis SA
    Arthritis Rheum; 2011 Sep; 63(9):2774-82. PubMed ID: 21618459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome.
    Truglia S; Mancuso S; Capozzi A; Recalchi S; Riitano G; Longo A; De Carolis S; Spinelli FR; Alessandri C; Ceccarelli F; De Carolis C; Misasi R; Sorice M; Conti F
    Rheumatology (Oxford); 2022 Feb; 61(2):826-833. PubMed ID: 33970223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
    Yasuda S; Bohgaki M; Atsumi T; Koike T
    Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
    Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
    Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
    Front Immunol; 2019; 10():460. PubMed ID: 30923525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome].
    Yasuda S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Dec; 27(6):373-8. PubMed ID: 15678890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-β
    Virachith S; Saito M; Watanabe Y; Inoue K; Hoshi O; Kubota T
    Clin Exp Immunol; 2019 Feb; 195(2):167-178. PubMed ID: 30368780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The β
    Tanimura K; Saito S; Nakatsuka M; Nagamatsu T; Fujii T; Fukui A; Deguchi M; Sasagawa Y; Arase N; Arase H; Yamada H
    Arthritis Rheumatol; 2020 Nov; 72(11):1882-1891. PubMed ID: 32583563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.
    Weiss R; Bitton A; Nahary L; Arango MT; Benhar I; Blank M; Shoenfeld Y; Chapman J
    Immunol Res; 2017 Feb; 65(1):355-362. PubMed ID: 27449504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mosaic of "seronegative" antiphospholipid syndrome.
    Conti F; Capozzi A; Truglia S; Lococo E; Longo A; Misasi R; Alessandri C; Valesini G; Sorice M
    J Immunol Res; 2014; 2014():389601. PubMed ID: 24741593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.
    Murthy V; Willis R; Romay-Penabad Z; Ruiz-Limón P; Martínez-Martínez LA; Jatwani S; Jajoria P; Seif A; Alarcón GS; Papalardo E; Liu J; Vilá LM; McGwin G; McNearney TA; Maganti R; Sunkureddi P; Parekh T; Tarantino M; Akhter E; Fang H; Gonzalez EB; Binder WR; Norman GL; Shums Z; Teodorescu M; Reveille JD; Petri M; Pierangeli SS
    Arthritis Rheum; 2013 Dec; 65(12):3186-93. PubMed ID: 23983008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.